| Outcome Measures: |
Primary: Time in target range, Time each participant spent with glucose level in target range (3.9 - 10.0 mmol/L), 4 weeks | Secondary: Time between 3.9 - 7.8 mmol/L, Percentage of time each participant spent with glucose levels between 3.9 - 7.8 mmol/L, 4 weeks|Time below 3,9, 3.3, and 2.8 mmol/L, Percentage of time each participant spent with glucose levels below 3.9, 3.3, and 2.8 mmol/L, 4 weeks|Time above 7.8, 10.0, 13.9, 16.7 mmol/L, Percentage of time each participant spent with glucose levels above 7.8, 10.0, 13.9, and 16.7 mmol/L, 4 weeks|Mean glucose level, Each participant's mean glucose level, 4 weeks|Total insulin delivery, Each participant's total insulin delivery, 4 weeks|Standard deviation and coefficient of variance, Each participant's standard deviation and coefficient of variance of glucose levels as a measure of glucose variability, 4 weeks|Gastrointestinal symptoms, Number of each participant's gastrointestinal symptoms, 4 weeks|Number of hypoglycemia events, Each participant's number of hypoglycemia events defined as at least 15 min below 3.0 mmol/L with the end of the event being 15 minutes \> 3.9 mmol/L., 4 weeks
|
